88 related articles for article (PubMed ID: 22266863)
81. Genetic changes in squamous cell lung cancer: a review.
Heist RS; Sequist LV; Engelman JA
J Thorac Oncol; 2012 May; 7(5):924-33. PubMed ID: 22722794
[TBL] [Abstract][Full Text] [Related]
82. [Research status on molecular targeted therapy for squamous-cell lung cancer].
Li Y; Zhou Y; Wang H
Zhongguo Fei Ai Za Zhi; 2014 Aug; 17(8):618-24. PubMed ID: 25130969
[TBL] [Abstract][Full Text] [Related]
83. Update on the Treatment of Metastatic Squamous Non-Small Cell Lung Cancer in New Era of Personalized Medicine.
Soldera SV; Leighl NB
Front Oncol; 2017; 7():50. PubMed ID: 28396848
[TBL] [Abstract][Full Text] [Related]
84. Genetic insight and therapeutic targets in squamous-cell lung cancer.
Sos ML; Thomas RK
Oncogene; 2012 Nov; 31(46):4811-4. PubMed ID: 22266863
[TBL] [Abstract][Full Text] [Related]
85. [Advances of molecular targeted therapy in squamous cell lung cancer].
Ma L; Zhang S
Zhongguo Fei Ai Za Zhi; 2013 Dec; 16(12):671-5. PubMed ID: 24345494
[TBL] [Abstract][Full Text] [Related]
86. Discoidin domain receptor 2 signaling networks and therapy in lung cancer.
Payne LS; Huang PH
J Thorac Oncol; 2014 Jun; 9(6):900-4. PubMed ID: 24828669
[TBL] [Abstract][Full Text] [Related]
87. Anaplastic lymphoma kinase rearrangement in lung cancer: its biological and clinical significance.
Toyokawa G; Seto T
Respir Investig; 2014 Nov; 52(6):330-8. PubMed ID: 25453376
[TBL] [Abstract][Full Text] [Related]
88. Treatment of advanced non-small-cell lung cancer with epidermal growth factor receptor (EGFR) mutation or ALK gene rearrangement: results of an international expert panel meeting of the Italian Association of Thoracic Oncology.
Gridelli C; de Marinis F; Cappuzzo F; Di Maio M; Hirsch FR; Mok T; Morgillo F; Rosell R; Spigel DR; Yang JC; Ciardiello F
Clin Lung Cancer; 2014 May; 15(3):173-81. PubMed ID: 24486058
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
